Anders Hove

M.Sc., Biotechnology Engineering, Technical University of Denmark; M.D., University of Copenhagen; M.B.A., INSEAD Anders has been with Venrock since 2004, applying his extensive knowledge in both venture capital and pharmaceutical operations to biotechnology companies at all stages. His experience in executive positions with the medical, clinical and business operations of the pharmaceuticals division of Ciba-Geigy led to his work as the CEO of Bellevue Asset Management. At Bellevue, Anders had responsibility for managing BB Biotech, an investment company with $1.6 billion invested in public and private companies, and he led numerous transactions in both. In 2011, Anders was named to Forbes' Midas List, which ranks the top venture capitalists in life sciences and technology.